Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: SARS-CoV-2 R.1 Variant   Sep 23, 2021  2 years, 6 months, 3 weeks, 3 days, 12 hours, 16 minutes ago

BREAKING! Prospective ‘Omega’ SARS-CoV-2 Variant Has Reemerged In Time For Fall And Winter! The R.1 Variant From Japan, Now In U.S. And Spreading Globally!

BREAKING! Prospective ‘Omega’ SARS-CoV-2 Variant Has Reemerged In Time For Fall And Winter! The R.1 Variant From Japan, Now In U.S. And Spreading Globally!
Source: SARS-CoV-2 R.1 Variant   Sep 23, 2021  2 years, 6 months, 3 weeks, 3 days, 12 hours, 16 minutes ago
R.1 Variant: A new SARS-CoV-2 variant called R.1 has reemerged after months of gaining viral fitness and relevant mutations on its genome to make it truly virulent, potent, extremely transmissible and immune evasive. The R.1 may be easier to contract due to protein mutations within the spike protein of the virus and its ability to be easily transmitted from person to person despite vaccination status does have scientists on edge.

 Although this variant was first identified in Tokyo, Japan early as December 2020, https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009619
 
https://onlinelibrary.wiley.com/doi/10.1002/jmv.27240
 
https://www.medrxiv.org/content/10.1101/2021.03.16.21253248v1
it had not gained much mutations in its genome yet and coupled the fact that the arrogant Western world and Western researchers typically are not interested in what is developing in Asia, not many were paying careful attention to the developments of this new identified variant. It also did not help that the GISAID and Nextstrain platforms have limitations in reporting and accurately detecting mutation developments on emerging SARS-CoV-2 variants in great detail.
 
The variant was also detected by French researchers in Marseille between February and April 2021. https://www.mediterranee-infection.com/wp-content/uploads/2020/04/Ms_Colson_ArchVirol_Jul2021_vL_IHUPreprint.pdf
 
A former Harvard Medical School professor and infectious disease expert Dr William A Haseltine was the only western scientists paying careful attention to this variant and studying in detail its evolution and mutation changes along with experts from the Access Health International platform.
 
So now in late September 2021, at the start of fall, we finally have the emergence of variant that has gained the necessary viral fitness and is fast spreading around the whole with very little attention being paid to it and the inadequate genomic surveillance by many countries is also helping in its spread.
 
The R.1 variant was easily replaced by the Alpha and Delta variants but has now because of evolution and gained viral fitness , been revived and is expected to replace the Delta variant in a matter of weeks.
 
From the analysis of the GISAID SARS-CoV-2 database, the variant has infected over 10,000 people globally and is fast spreading and has already been detected in various States in the U.S. including in a nursing home in Kentucky where it infected 45 residents and healthcare workers.

The new variant is related to the original coronavirus strain and contains "many unique mutations" that can lead to “increased resistance to antibodies in convalescent sera and to neutralizing antibodies that empowers it to bypass antibodies in a victim.
 
It h as been found that the evolved variant was successful in affecting multiple vaccinated people by circumventing antibodies.
 
The R.1.variant shares the highly infectious D614G mutation that is present in other variants of concern such as the Delta, Alpha, Beta and Gamma.
 
The R.1.variant contains five mutations previously noted in variants of concern or interest, two of which are in the Spike